Lobbying client · LD-2 disclosures
Vifor Pharma Ltd
Switzerland
55 filings from 1 registrant · 2012–2025 · latest filed Oct 17, 2025
Reported on its behalf
$2.1M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$2.1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
49 filings
$2.1M on those filings
Medicare/Medicaid
MMM
3 filings
$80K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 1576 114th CongressGeneric Complex Drugs Safety and Effectiveness for Patients Act of 20157 filingsthrough 2016
- H.R. 1576 115th CongressInnovation Corps Act of 20174 filingsthrough 2017
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Patricia Louise Deloatche Sidley Austin LLPCovered position: Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis50 filingsthrough 2025
- Peter M Goodloe Sidley Austin LLPCovered position: Legislative Counsel, House Energy & Commerce; Legislative Counsel, House Office of Legislative17 filingsthrough 2015
- Dora Hughes Sidley Austin LLPCovered position: Deputy Director of Health, HELP, Sen. Edward Kennedy; Health Policy Advisor, Sen. Barack Obama; Counselor for Science and Public Health, HHS8 filingsthrough 2018
- Tracey Laturner
The filings
The 20 most recent of 55 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: vifor-pharma-ltd.